Cite
HARVARD Citation
Uchida, Y. et al. (2020). Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis. Hepatology research. 50 (11), pp. 1264-1274. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Uchida, Y. et al. (2020). Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis. Hepatology research. 50 (11), pp. 1264-1274. [Online].